Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026)

Updated

Northwest Biotherapeutics (NWBO) reported Preferred Dividend Payments of $332,000 for Q2 2026, down 40.7% from $560,000 a year earlier but up 0.3% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Northwest Biotherapeutics' Preferred Dividend Payments came in at $1.15 million, down 6.3% year-over-year; for FY2025, it was $1.32 million, down 7.0% from FY2024.

  • By year, Preferred Dividend Payments came in at $1.41 million in FY2024 (-21.4%) and $1.8 million in FY2023.
  • Five-year quarterly Preferred Dividend Payments spans a low of $132,000 in Q3 2024 and a high of $568,000 in Q1 2024.
  • Year over year, Preferred Dividend Payments gained in three of the last eight quarters, with an average decline of 3.1%.
  • The high point for year-over-year Preferred Dividend Payments in five years was Q3 2025 (growth of 167.4%); the low point was Q3 2024 (a decline of 74.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $331,000 (Q1 2026), $137,000 (Q4 2025) and $353,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 332,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 332,000.00
Mar 31, 2026 331,000.00
Dec 31, 2025 137,000.00
Sep 30, 2025 353,000.00
Jun 30, 2025 560,000.00
Mar 31, 2025 265,000.00
Dec 31, 2024 273,000.00
Sep 30, 2024 132,000.00
Jun 30, 2024 441,000.00
Mar 31, 2024 568,000.00
Dec 31, 2023 367,000.00
Sep 30, 2023 519,000.00
Jun 30, 2023 519,000.00
Mar 31, 2023 395,000.00
Sep 30, 2018 4.18 Mn
Jun 30, 2018 3.54 Mn
Mar 31, 2018 10.06 Mn
Dec 31, 2017 1.27 Mn
Sep 30, 2016 3.01 Mn
Jun 30, 2016 2.64 Mn
API Access

Northwest Biotherapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=NWBO&period=max&api_key=YOUR_API_KEY